Clinical Laserthermia Systems Announces Agreement with AVANT Concierge Urology to Treat Prostate Cancer Patients with TRANBERG Thermal Therapy System
Lund, Sweden – April 19, 2023 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announces that their US subsidiary CLS Americas has signed a Mobile Service Provider (MSP) Agreement with AVANT Concierge Urology of Winterhaven, FL.
Under the agreement, AVANT will begin using the CLS TRANBERG Thermal Therapy System to treat patients with early-intermediate stage prostate cancer. According to the agreement, CLS provides its 510(k) cleared TRANBERG Thermal Therapy System, with consumable accessories, training, and on-site clinical and technical support to AVANT physicians and staff during procedures, for a case fee.
“AVANT Concierge Urology is one of the most advanced and state-of-the art urology facilities and practices on the US market today,” noted Michael Magnani, president of CLS Americas. “CLS Americas is honored to work with AVANT and Dr. Parekattil, Director of AVANT, to implement the use of our TRANBERG system as a flexible, cost- effective service for patient treatments that works well with AVANT´s well-established business model.”
"It is our opinion that the share of full-service agreements in the urology segment in the US is increasing as it reduces the business risk for both the urology practice and the medical technology provider. CLS MSP agreement offers a good deal for both our customers and CLS and means that more and more prostate cancer patients can access targeted, minimally invasive, prostate tumor treatments, conducted with CLS TRANBERG systems, at a faster pace", says Dan J Mogren, CEO of CLS AB.
For more information, please contact:
Dan J. Mogren, CEO, Clinical Laserthermia Systems AB (publ)
Phone: +46 (0) 70-590 11 40
E-mail: dan.mogren@clinicallaser.com
About Avant Concierge Urology
Avant Concierge Urology is Central Florida’s premier urology practice, specializing in the treatment of conditions related to the kidneys, urinary bladder, adrenal glands, urethra, and male reproductive organs. Regardless of whether you’re male or female, you can count on Avant for the personalized care you deserve. In addition to helping to provide optimal health for the organs of the genitourinary tract, Avant offers best-in-class surgical treatment options, with the intent to minimize downtime, scarring, and expenses.
For more information, visit: https://avanturol.com/.
About CLS
Clinical Laserthermia Systems AB (publ) develops and sells the TRANBERG®|Thermal Therapy Systems, including Thermoguide Workstation and sterile disposables, for minimally invasive treatment of cancer tumors and drug-resistant epilepsy, according to regulatory approvals in the EU and the US. The products are marketed for image-guided laser ablation and used in studies for treatment with imILT®, the Company's interstitial laser thermotherapy for immunostimulant ablation with potential abscopal effects. CLS is headquartered in Lund and has subsidiaries in Germany, the US and Singapore. CLS is listed on the Nasdaq First North Growth Market under the symbol CLS B. The Certified Advisor (CA) is FNCA Sweden AB, Tel: +46 8 528 00 399. E-mail: info@fnca.se.
For more information about CLS, please visit the Company's website: clinicallaser.se.